The Food and Drug Administration (FDA) has approved HemiClor ™, a low dose formulation of chlorthalidone, for the treatment of hypertension in adults, to lower blood pressure.

Narsoplimab is a human monoclonal antibody that specifically targets mannan-binding lectin-associated serine protease-2.

Reproxalap is a first-in-class small-molecule modulator of reactive aldehyde species, which are generally elevated in ocular and systemic inflammatory disease.

HealthDay News — More US children have died from the flu this season than in any year since the 2009 swine flu pandemic, according to a new federal report.

Seven percent of 108 healthy volunteers reported urticaria; unresolved urticaria persisted at 12 months in four participants.

Friede's passion nearly cost him his life in 2001, when he let 2 cobras bite him and ended up in a coma for four days.

The patient's medical history included obesity, asthma, possible sleep apnea, and a potentially deviated septum.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for milsaperidone (Bysanti™) for the treatment of acute ...

HealthDay News — The US Department of Health and Human Services and the National Institutes of Health announced a new initiative called “Generation Gold Standard” to develop next-generation, universal ...

HealthDay News — Six in 10 women believe they will hit menopause in their 40s, according to survey results released April 8 by The Ohio State University Wexner Medical Center in Columbus.

ATH434 is designed to reduce α-synuclein aggregation and oxidative stress by binding to and redistributing excess loosely bound iron in the brain.

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on ...